120 related articles for article (PubMed ID: 34268316)
1. Corrigendum: An MRTF-A-Sp1-PDE5 Axis Mediates Angiotensin-II-Induced Cardiomyocyte Hypertrophy.
Wu T; Wang H; Xin X; Zhang T; Yang J; Hou Y; Fang M; Lu X; Xu Y
Front Cell Dev Biol; 2021; 9():711764. PubMed ID: 34268316
[TBL] [Abstract][Full Text] [Related]
2. An MRTF-A-Sp1-PDE5 Axis Mediates Angiotensin-II-Induced Cardiomyocyte Hypertrophy.
Wu T; Wang H; Xin X; Yang J; Hou Y; Fang M; Lu X; Xu Y
Front Cell Dev Biol; 2020; 8():839. PubMed ID: 33015041
[TBL] [Abstract][Full Text] [Related]
3. Endothelial MRTF-A mediates angiotensin II induced cardiac hypertrophy.
Weng X; Yu L; Liang P; Chen D; Cheng X; Yang Y; Li L; Zhang T; Zhou B; Wu X; Xu H; Fang M; Gao Y; Chen Q; Xu Y
J Mol Cell Cardiol; 2015 Mar; 80():23-33. PubMed ID: 25446178
[TBL] [Abstract][Full Text] [Related]
4. Corrigendum: An Interplay Between MRTF-A and the Histone Acetyltransferase TIP60 Mediates Hypoxia-Reoxygenation Induced iNOS Transcription in Macrophages.
Yang Y; Yang G; Yu L; Lin L; Liu L; Fang M; Xu Y
Front Cell Dev Biol; 2021; 9():657122. PubMed ID: 33644081
[TBL] [Abstract][Full Text] [Related]
5. Corrigendum: An Interplay Between MRTF-A and the Histone Acetyltransferase TIP60 Mediates Hypoxia-Reoxygenation Induced iNOS Transcription in Macrophages.
Yang Y; Yang G; Yu L; Lin L; Liu L; Fang M; Xu Y
Front Cell Dev Biol; 2021; 9():650002. PubMed ID: 33585494
[TBL] [Abstract][Full Text] [Related]
6. Corrigendum: BRG1 Stimulates Endothelial Derived Alarmin MRP8 to Promote Macrophage Infiltration in an Animal Model of Cardiac Hypertrophy.
Li Z; Zhang Y; Zhang Y; Yu L; Xiao B; Li T; Kong X; Xu Y
Front Cell Dev Biol; 2021; 9():650029. PubMed ID: 33575261
[TBL] [Abstract][Full Text] [Related]
7. Myocardin-related transcription factor-A induces cardiomyocyte hypertrophy.
Liao XH; Wang N; Liu QX; Qin T; Cao B; Cao DS; Zhang TC
IUBMB Life; 2011 Jan; 63(1):54-61. PubMed ID: 21280178
[TBL] [Abstract][Full Text] [Related]
8. (-)-Epicatechin Suppresses Angiotensin II-induced Cardiac Hypertrophy via the Activation of the SP1/SIRT1 Signaling Pathway.
Dong ZX; Wan L; Wang RJ; Shi YQ; Liu GZ; Zheng SJ; Hou HL; Han W; Hai X
Cell Physiol Biochem; 2017; 41(5):2004-2015. PubMed ID: 28420000
[TBL] [Abstract][Full Text] [Related]
9. HMG-CoA reductase inhibitor fluvastatin prevents angiotensin II-induced cardiac hypertrophy via Rho kinase and inhibition of cyclin D1.
Morikawa-Futamatsu K; Adachi S; Maejima Y; Tamamori-Adachi M; Suzuki J; Kitajima S; Ito H; Isobe M
Life Sci; 2006 Aug; 79(14):1380-90. PubMed ID: 16712874
[TBL] [Abstract][Full Text] [Related]
10. Sp1-induced LncRNA CTBP1-AS2 is a novel regulator in cardiomyocyte hypertrophy by interacting with FUS to stabilize TLR4.
Luo X; He S; Hu Y; Liu J; Chen X
Cardiovasc Pathol; 2019; 42():21-29. PubMed ID: 31220774
[TBL] [Abstract][Full Text] [Related]
11. SP1-SYNE1-AS1-miR-525-5p feedback loop regulates Ang-II-induced cardiac hypertrophy.
Wang Y; Cao R; Yang W; Qi B
J Cell Physiol; 2019 Aug; 234(8):14319-14329. PubMed ID: 30652310
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II type-1 receptor-JAK/STAT pathway mediates the induction of visfatin in angiotensin II-induced cardiomyocyte hypertrophy.
Chang L; Yang R; Wang M; Liu J; Wang Y; Zhang H; Li Y
Am J Med Sci; 2012 Mar; 343(3):220-6. PubMed ID: 21841463
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin type 1 receptor mediates thyroid hormone-induced cardiomyocyte hypertrophy through the Akt/GSK-3beta/mTOR signaling pathway.
Diniz GP; Carneiro-Ramos MS; Barreto-Chaves ML
Basic Res Cardiol; 2009 Nov; 104(6):653-67. PubMed ID: 19588183
[TBL] [Abstract][Full Text] [Related]
14. MiR-27a-3p/Hoxa10 Axis Regulates Angiotensin II-Induced Cardiomyocyte Hypertrophy by Targeting Kv4.3 Expression.
Cao X; Zhang Z; Wang Y; Shan W; Wang R; Mao S; Ding S; Pang C; Li B; Zhou J; Guo X; Guo N; Li C; Liang J; Ma W; Liu Y; Zhao L
Front Pharmacol; 2021; 12():680349. PubMed ID: 34248630
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-92b-3p suppresses angiotensin II-induced cardiomyocyte hypertrophy via targeting HAND2.
Yu XJ; Huang YQ; Shan ZX; Zhu JN; Hu ZQ; Huang L; Feng YQ; Geng QS
Life Sci; 2019 Sep; 232():116635. PubMed ID: 31283925
[TBL] [Abstract][Full Text] [Related]
16. Sialyltransferase7A promotes angiotensin II-induced cardiomyocyte hypertrophy via HIF-1α-TAK1 signalling pathway.
Yan X; Zhao R; Feng X; Mu J; Li Y; Chen Y; Li C; Yao Q; Cai L; Jin L; Han C; Zhang D
Cardiovasc Res; 2020 Jan; 116(1):114-126. PubMed ID: 30854566
[TBL] [Abstract][Full Text] [Related]
17.
Cho S; Cho HW; Woo KW; Jeong J; Lim J; Park S; Seo M; Lim S
Molecules; 2019 Apr; 24(9):. PubMed ID: 31027372
[No Abstract] [Full Text] [Related]
18. Corrigendum to: CXCL1-CXCR2 axis mediates angiotensin II-induced cardiac hypertrophy and remodelling through regulation of monocyte infiltration.
Eur Heart J; 2019 Jan; 40(1):49. PubMed ID: 29635406
[No Abstract] [Full Text] [Related]
19. sRAGE attenuates angiotensin II-induced cardiomyocyte hypertrophy by inhibiting RAGE-NFκB-NLRP3 activation.
Lim S; Lee ME; Jeong J; Lee J; Cho S; Seo M; Park S
Inflamm Res; 2018 Aug; 67(8):691-701. PubMed ID: 29796842
[TBL] [Abstract][Full Text] [Related]
20. Rap1GAP Mediates Angiotensin II-Induced Cardiomyocyte Hypertrophy by Inhibiting Autophagy and Increasing Oxidative Stress.
Gao Y; Zhao D; Xie WZ; Meng T; Xu C; Liu Y; Zhang P; Bi X; Zhao Z
Oxid Med Cell Longev; 2021; 2021():7848027. PubMed ID: 33936386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
